Prolactinoma classification: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(33 intermediate revisions by 7 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Prolactinoma}}
{{Prolactinoma}}
{{CMG}} {{AE}}{{Faizan}}
{{CMG}};{{AE}} {{Faizan}}, {{Anmol}}
 
==Overview==
==Overview==
 
[[Prolactinoma]] can be classified based upon either size or local invasion. Based on size, a prolactinoma can be classified as a microprolactinoma (<10 mm diameter) or macroprolactinoma (>10 mm diameter).
Based on size, a prolactinoma can be classified as a 'microprolactinoma'' (<10 mm diameter) or ''macroprolactinoma'' (>10 mm diameter).


==Classification==
==Classification==
Prolactinoma may be classified based on either size or local invasion.


Prolactinoma may be classified based on either size or location.
{|
 
! colspan="4" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF| Classification of prolactinoma}}
===Based on size===
|-
 
! colspan="2" style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Classification basis}}
A prolactinoma can be classified as
! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Type/Grade}}
 
! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Criteria}}
*''microprolactinoma'' (<10 mm diameter)
|-
 
| colspan="2" rowspan= "2" style="background: #DCDCDC; text-align: center;" |Classification based on size<ref name="pmid15274075">{{cite journal |vauthors=Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE |title=The prevalence of pituitary adenomas: a systematic review |journal=Cancer |volume=101 |issue=3 |pages=613–9 |year=2004 |pmid=15274075 |doi=10.1002/cncr.20412 |url=http://onlinelibrary.wiley.com/doi/10.1002/cncr.20412/full}}</ref>
*''macroprolactinoma'' (>10 mm diameter)
| style="background: #F5F5F5; text-align: center;" |Microprolactinoma
===Based on location===
| style="background: #F5F5F5;" | <10 mm diameter
 
|-
The classification for pituitary adenomas is as follows:
| style="background: #F5F5F5; text-align: center;" |Macroprolactinoma
 
| style="background: #F5F5F5;" | >10 mm diameter
*0: Normal [[pituitary]] appearance.
|-
 
| rowspan="11" style="background: #DCDCDC; text-align: center;" |Classificatioin based on local invasion<ref name="urlPituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute">{{cite web |url=https://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#cit/section_3.3 |title=Pituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute |format= |work= |accessdate=}}</ref><ref name="pmid09436654">{{cite journal| author=Yeh PJ, Chen JW| title=Pituitary tumors: surgical and medical management. | journal=Surg Oncol | year= 1997 | volume= 6 | issue= 2 | pages= 67-92 | pmid=09436654 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9436654  }}</ref><ref>Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute,  January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98</ref>
*I:                         Enclosed within the sella turcica, microadenoma, smaller than 10 mm
| rowspan="5" style="background: #DCDCDC; text-align: center;" |Size and Invasion
 
| style="background: #F5F5F5; text-align: center;" |0
*II: Enclosed within the [[sella turcica]], macroadenoma, 10 mm or larger
| style="background: #F5F5F5;" |Normal [[pituitary]] appearance
 
|-
*III: Invasive, locally, into the sella
| style="background: #F5F5F5; text-align: center;" |I
 
| style="background: #F5F5F5;" |Enclosed within the [[sella turcica]], microadenoma smaller than 10 mm
*IV: Invasive, diffusely, into the sella
|-
 
| style="background: #F5F5F5; text-align: center;" |II
The grading schema for suprasellar extensions is as follows:
| style="background: #F5F5F5;" |Enclosed within the [[sella turcica]], macroadenoma 10 mm or larger
 
|-
*A:  0 to 10 mm suprasellar extension occupying the suprasellar cistern
| style="background: #F5F5F5; text-align: center;" |III
 
| style="background: #F5F5F5;" |Invasive, locally, into the [[sella turcica]]
*B: 10 mm  to 20 mm extension and elevation of the third [[ventricle]]
|-
 
| style="background: #F5F5F5; text-align: center;" |IV
*C: 20 mm to 30 mm extension occupying the anterior of the third ventricle
| style="background: #F5F5F5;" |Invasive, diffusely, into the [[sella turcica]]
 
|-
*D: A larger than 30 mm extension, beyond the foramen of Monro, or Grade C with lateral extensions<ref>http://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#section/_3</ref><ref>Yeh PJ, Chen JW: Pituitary tumors: surgical and medical management. Surg Oncol 6 (2): 67-92, 1997. [PUBMED Abstract]</ref><ref>Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute,  January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98</ref>
| rowspan="4" style="background: #DCDCDC; text-align: center;" |Grading scheme for suprasellar extensions
| style="background: #F5F5F5; text-align: center;" |A
| style="background: #F5F5F5;" |0 to 10 mm [[suprasellar]] extension occupying the [[suprasellar]]cistern
|-
| style="background: #F5F5F5; text-align: center;" |B
| style="background: #F5F5F5;" |10 mm  to 20 mm extension and elevation of the [[third ventricle]]
|-
| style="background: #F5F5F5; text-align: center;" |C
| style="background: #F5F5F5;" |20 mm to 30 mm extension occupying the [[anterior]] of the [[third ventricle]]
|-
| style="background: #F5F5F5; text-align: center;" |D
| style="background: #F5F5F5;" |A larger than 30 mm extension, beyond the [[foramen of Monro]], or Grade C with lateral extensions
|}


== References ==
== References ==
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Disease]]
[[Category:Neuroendocrinology]]
[[Category:Neuroendocrinology]]
[[Category:Mature chapter]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Endocrinology]]
[[Category:Up-To-Date]]
[[Category:Neurology]]
[[Category:Neurosurgery]]

Latest revision as of 23:49, 29 July 2020

Prolactinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prolactinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Prolactinoma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prolactinoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prolactinoma classification

CDC on Prolactinoma classification

Prolactinoma classification in the news

Blogs on Prolactinoma classification

Directions to Hospitals Treating Prolactinoma

Risk calculators and risk factors for Prolactinoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2], Anmol Pitliya, M.B.B.S. M.D.[3]

Overview

Prolactinoma can be classified based upon either size or local invasion. Based on size, a prolactinoma can be classified as a microprolactinoma (<10 mm diameter) or macroprolactinoma (>10 mm diameter).

Classification

Prolactinoma may be classified based on either size or local invasion.

Classification of prolactinoma
Classification basis Type/Grade Criteria
Classification based on size[1] Microprolactinoma <10 mm diameter
Macroprolactinoma >10 mm diameter
Classificatioin based on local invasion[2][3][4] Size and Invasion 0 Normal pituitary appearance
I Enclosed within the sella turcica, microadenoma smaller than 10 mm
II Enclosed within the sella turcica, macroadenoma 10 mm or larger
III Invasive, locally, into the sella turcica
IV Invasive, diffusely, into the sella turcica
Grading scheme for suprasellar extensions A 0 to 10 mm suprasellar extension occupying the suprasellarcistern
B 10 mm to 20 mm extension and elevation of the third ventricle
C 20 mm to 30 mm extension occupying the anterior of the third ventricle
D A larger than 30 mm extension, beyond the foramen of Monro, or Grade C with lateral extensions

References

  1. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004). "The prevalence of pituitary adenomas: a systematic review". Cancer. 101 (3): 613–9. doi:10.1002/cncr.20412. PMID 15274075.
  2. "Pituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute".
  3. Yeh PJ, Chen JW (1997). "Pituitary tumors: surgical and medical management". Surg Oncol. 6 (2): 67–92. PMID 09436654.
  4. Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute, January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98

Template:WikiDoc Sources